- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Inhibitory Effect of Peptide-Free Forms of Advanced Glycation End Products on the Proliferation and Extracellular Matrix Protein Production of Cultured Cells.
-
- Yoshihara Kazuhiro
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
-
- Okumura Tomohide
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
-
- Yoshida Tomonobu
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
-
- Beppu Masatoshi
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
Search this article
Description
Advanced glycation end products (AGEs), generated by the Maillard reaction, accumulate in long-lived proteins like collagen and are presumed to be involved in aging and the pathogenesis of complications in diabetes. We investigated the effect of peptide-free forms of AGEs that can be released by the catabolism of AGE-proteins on cellular activities using cultured cells and synthetic AGEs, pentosidine and pyrraline. The exposure of cultured fibroblasts to 15 or 30 μM of pentosidine resulted in the partial inhibition of cell proliferation and production of extracellular matrix (ECM) proteins. Pentosidine also inhibited the proliferation and ECM protein production of chondrocytes, but its effect on cell proliferation was weak while that on ECM production was prominent, as compared with the effect of pentosidine. A similar inhibitory effect on cell proliferation was observed when fibroblasts or chondrocytes were exposed to pyrraline. Pentosidine and pyrraline did not cause cell death in these cells. Pentosidine appeared to enter the cells during the culture. These results suggest that peptide-free forms of AGEs affect cell growth and cell metabolism by acting both extracellularly and intracellularly.
Journal
-
- Journal of Health Science
-
Journal of Health Science 47 (3), 296-301, 2001
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204497186688
-
- NII Article ID
- 110003641406
-
- NII Book ID
- AA11316464
-
- COI
- 1:CAS:528:DC%2BD3MXktVygsLw%3D
-
- ISSN
- 13475207
- 13449702
-
- NDL BIB ID
- 5798965
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed